eMed, previously known as Cortrack, a privately held, development stage company, creates drug delivery catheters that transport drugs to a specific location within the body. Initially, the company is focusing on treating and/or preventing problems associated with coronary angioplasty.
How Sourced: CEO, Venture Board member
Our involvement: Development of structure, valuation, and negotiation strategies with potential strategic alliance partners.
